Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG vs Plasmapheresis in Guillain-Barré Syndrome
NCT05104762Phase 3Completed
- Sponsor
- Assiut University
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in Guillain-Barré syndrome (GBS), sponsored by Assiut University. Started Sep 2021; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
Guillain-Barré syndrome (GBS)
Beyond the preview
Go deeper on NCT05104762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05104762.